For research use only. Not for therapeutic Use.
Ar-V7-IN-1（Cat No.:I044004）is a small molecule inhibitor designed to target and block the activity of androgen receptor splice variant 7 (AR-V7), a mutant form of the androgen receptor associated with resistance to androgen deprivation therapy in prostate cancer. AR-V7 is implicated in the progression of castration-resistant prostate cancer (CRPC). By inhibiting AR-V7, Ar-V7-IN-1 aims to overcome treatment resistance and improve therapeutic outcomes for patients with CRPC. This compound is being explored as a potential therapeutic agent to enhance the effectiveness of current prostate cancer treatments.
| CAS Number | 2230880-25-6 |
| Synonyms | 4-[4-(4,5-dibromoimidazol-1-yl)-1,3-thiazol-2-yl]morpholine |
| Molecular Formula | C10H10Br2N4OS |
| Purity | ≥95% |
| IUPAC Name | 4-[4-(4,5-dibromoimidazol-1-yl)-1,3-thiazol-2-yl]morpholine |
| InChI | InChI=1S/C10H10Br2N4OS/c11-8-9(12)16(6-13-8)7-5-18-10(14-7)15-1-3-17-4-2-15/h5-6H,1-4H2 |
| InChIKey | KEFGZKYLWGZFFS-UHFFFAOYSA-N |
| SMILES | C1COCCN1C2=NC(=CS2)N3C=NC(=C3Br)Br |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
